Search Results - "Stewart, F Marc"

Implementing a Death with Dignity Program at a Comprehensive Cancer Center by Loggers, Elizabeth Trice, Starks, Helene, Shannon-Dudley, Moreen, Back, Anthony L, Appelbaum, Frederick R, Stewart, F. Marc

“…Investigators from the Seattle Cancer Care Alliance describe their implementation of a Death with Dignity program in compliance with Washington State law. In…”
Get full text

Human Herpesvirus 6B and Lower Respiratory Tract Disease After Hematopoietic Cell Transplantation by Hill, Joshua A, Vande Vusse, Lisa K, Xie, Hu, Chung, E Lisa, Yeung, Cecilia C S, Seo, Sachiko, Stevens-Ayers, Terry, Fisher, Cynthia E, Huang, Meei-Li, Stewart, F Marc, Jerome, Keith R, Zerr, Danielle M, Corey, Lawrence, Leisenring, Wendy M, Boeckh, Michael

“…Human herpesvirus 6B (HHV-6B) DNA is frequently detected in bronchoalveolar lavage fluid (BALF) from immunocompromised subjects with lower respiratory tract…”
Get full text

Mitigation strategies for anti‐D alloimmunization by platelet transfusion in haematopoietic stem cell transplant patients: a survey of NCCN® centres by Poston, Jacqueline N., Sugalski, Jessica, Gernsheimer, Terry B., Marc Stewart, F., Pagano, Monica B.

“…Background and objectives D‐negative patients are at risk of developing an alloantibody to D (anti‐D) if exposed to D during transfusion. The presence of…”
Get full text

Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach by Ueda Oshima, Masumi, Sandmaier, Brenda M., Petersdorf, Effie, Flowers, Mary E., Hill, Geoffrey R., Lee, Stephanie J., Appelbaum, Frederick R., Carpenter, Paul A., Baker, K. Scott, Connelly-Smith, Laura, McCool, Andrea, Elgar, Suni, Pergam, Steven A., Liu, Catherine, Stewart, F. Marc, Mielcarek, Marco

“…On January 20, 2020, the first patient with coronavirus disease 2019 (COVID-19) in the United States of America was diagnosed in Washington state, which…”
Get full text

Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report by Appelbaum, Jacob, Wells, David, Hiatt, Joseph B, Steinbach, Gideon, Stewart, F Marc, Thomas, Hannah, Nghiem, Paul, Kapur, Raj P, Thompson, John A, Bhatia, Shailender

“…Immune checkpoint inhibitors (ICIs) are the treatment of choice for several cancers and can be associated with remarkable clinical benefit, but can also cause…”
Get full text

NCCN Roundtable: What Are the Characteristics of an Optimal Clinical Practice Guideline? by Ettinger, David S, Kuettel, Michael, Malin, Jennifer, McClure, Joan S, Smith, Mary Lou, Zelenetz, Andrew D, Stewart, F Marc

“…Much has changed in the treatment of cancer since the first NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) were rolled out for 8 different…”
Get more information

Care Patterns and Barriers to Outpatient Care for Adults With AML Following Intensive Chemotherapy at NCCN Member Institutions by Halpern, Anna B, Sugalski, Jessica M, Bandini, Lindsey, Othus, Megan, Stewart, F Marc, Walter, Roland B

“…Prolonged hospitalization following intensive (re)induction chemotherapy for acute myeloid leukemia (AML), while standard, is costly and resource intense,…”
Get more information

NCCN Oncology Risk Evaluation and Mitigation Strategies White Paper: Recommendations for Stakeholders by Johnson, Philip E, Dahlman, George, Eng, Kirby, Garg, Rekha, Gottlieb, Scott, Hoffman, James M, Howell, Peyton, Jahanzeb, Mohammad, Johnson, Shirley, Mackler, Emily, Rubino, Mark, Sarokhan, Brenda, Marc Stewart, F, Tyler, Tim, Vose, Julie M, Weinstein, Sharon, Li, Edward C, Demartino, Jessica

“…REMS are a particularly important issue for oncology and the National Comprehensive Cancer Network (NCCN). A disproportionate number of drugs with complex REMS…”
Get more information

High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda study by Weiss, Raymond B, Rifkin, Robert M, Stewart, F Marc, Theriault, Richard L, Williams, Lori A, Herman, Allen A, Beveridge, Roy A

“…The efficacy of high-dose chemotherapy with progenitor-cell rescue for women with breast cancer is a controversial issue. Although historically controlled…”
Get full text

NCCN's Commitment to Medication Safety: The Vincristine Initiative by Sugalski, Jessica, Stewart, F Marc, Carlson, Robert W

“…The mission of NCCN is to improve the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Improving medication safety…”
Get more information

Responsibility for costs associated with clinical trials by Martin, Paul J, Davenport-Ennis, Nancy, Petrelli, Nicholas J, Stewart, F Marc, Appelbaum, Frederick R, Benson, 3rd, Al

Get full text

National Comprehensive Cancer Network Infusion Efficiency Workgroup Study: Optimizing Patient Flow in Infusion Centers by Sugalski, Jessica M, Kubal, Timothy, Mulkerin, Daniel L, Caires, Rebecca L, Moore, Penny J, Fiorarancio Fahy, Rosanna, Gordon, Jeanine N, Augustyniak, Connie Z, Szymanski, Gina M, Olsen, MiKaela, Frantz, Diedra K, Quinn, Marisa A, Kidd, Sharol K, Krause, Diana M, Carlson, Robert W, Stewart, F Marc

“…The National Comprehensive Cancer Network (NCCN) formed an Infusion Efficiency Workgroup to determine best practices for operating efficient and effective…”
Get full text

Appreciating the role of advanced practice providers in oncology by Levy, William, Gagnet, Suzanne, Stewart, F Marc

Get more information

Ensuring Patient Safety and Access in Cancer Care by Winckworth-Prejsnar, Katy, Nardi, Elizabeth A, McCanney, James, Stewart, F Marc, Langbaum, Terry, Gould, Bruce J, Fitzgerald, C Lyn, Carlson, Robert W

“…The inability to obtain the right high-quality cancer care in a timely and safe manner can have devastating results for patients. As cancer care becomes…”
Get more information

Addressing Drug Resistance in Cancer: A Team Medicine Approach by Kulkarni, Prakash, Mohanty, Atish, Bhattacharya, Supriyo, Singhal, Sharad, Guo, Linlin, Ramisetty, Sravani, Mirzapoiazova, Tamara, Mambetsariev, Bolot, Mittan, Sandeep, Malhotra, Jyoti, Gupta, Naveen, Kim, Pauline, Babikian, Razmig, Rajurkar, Swapnil, Subbiah, Shanmuga, Tan, Tingting, Nguyen, Danny, Merla, Amartej, Kollimuttathuillam, Sudarsan V, Phillips, Tanyanika, Baik, Peter, Tan, Bradford, Vashi, Pankaj, Shrestha, Sagun, Leach, Benjamin, Garg, Ruchi, Rich, Patricia L, Stewart, F Marc, Pisick, Evan, Salgia, Ravi

“…Drug resistance remains one of the major impediments to treating cancer. Although many patients respond well initially, resistance to therapy typically ensues…”
Get full text

Seroprevalence of Measles and Mumps Antibodies Among Individuals With Cancer by Marquis, Sara R, Logue, Jennifer K, Chu, Helen Y, Loeffelholz, Tillie, Quinn, Z Z, Liu, Catherine, Stewart, F Marc, Carpenter, Paul A, Pergam, Steven A, Krantz, Elizabeth M

“…Although patients with cancer are at an increased risk of infection-related complications, few studies have characterized their vulnerability to measles and…”
Get full text

Intensive Reinduction Chemotherapy Followed by Early Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory High-Grade Myeloid Neoplasms by Kopmar, Noam E., Othus, Megan, Quach, Kim, Rasmussen, Allegra, Schonhoff, Kelda, Becker, Pamela S., Walter, Roland B., Halpern, Anna B., Salit, Rachel, Cassaday, Ryan D., Shustov, Andrei, Stewart, F. Marc, Oehler, Vivian G., Scott, Bart L., Sandmaier, Brenda M., Lee, Stephanie J., Estey, Elihu H., Percival, Mary-Elizabeth M.

“…•Hematopoietic cell transplantation (HCT) remains the sole curative option for adults with relapsed/refractory (R/R) high-grade myeloid neoplasms.•Early HCT…”
Get full text

Hematopoietic Cell Transplantation as Curative Therapy for Idiopathic Myelofibrosis, Advanced Polycythemia Vera, and Essential Thrombocythemia by Kerbauy, Daniella M.B, Gooley, Theodore A, Sale, George E, Flowers, Mary E.D, Doney, Kristine C, Georges, George E, Greene, Joanne E, Linenberger, Michael, Petersdorf, Effie, Sandmaier, Brenda M, Scott, Bart L, Sorror, Mohamed, Stirewalt, Derek L, Stewart, F. Marc, Witherspoon, Robert P, Storb, Rainer, Appelbaum, Frederick R, Deeg, H. Joachim

“…Abstract A total of 104 patients, aged 18 to 70 years, with a diagnosis of chronic idiopathic myelofibrosis (CIMF), polycythemia vera (PV), or essential…”
Get full text

NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveys by Kurzrock, Razelle, Colevas, A Dimitrios, Olszanski, Anthony, Akerley, Wallace, Arteaga, Carlos L, Carson, 3rd, William E, Clark, Jeffrey W, DiPersio, John F, Ettinger, David S, Morgan, Jr, Robert J, Schwartzberg, Lee S, Venook, Alan P, Gocke, Christopher D, Tait, Jonathan, Stewart, F Marc

“…With advances such as next-generation sequencing (NGS) increasing understanding of the basis of cancer and its response to treatment, NCCN believes it is…”
Get more information

Development of a hematology/oncology ICD-10 documentation job aid by Martin, Daniel B, Silas, Sean, Covner, Audrey, Hendrie, Paul C, Stewart, F Marc

“…Conversion to the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) was mandated for October 1, 2014, but was delayed…”
Get more information